Background: It is well established that transient postoperative atrial fibrillation (TPAF) is associated with adverse postoperative outcomes after major cardiac and noncardiac operations. The purpose of this study was to elucidate the incidence, impact, and risk factors associated with the development of TPAF in patients undergoing revascularization surgery for occlusive diseases of the abdominal aorta and its branches (AAB).
Atrial fibrillation (AF) is the most common clinically relevant cardiac arrhythmia, and it is well established that its development as a chronic condition leads to increased morbidity and mortality. [1] [2] [3] AF is also the most common new-onset postoperative dysrhythmia and is associated with adverse early surgical outcomes. Although it has been thought to be relatively benign and self-limited in the noncardiothoracic setting, its deleterious long-term effects have recently been recognized to extend beyond the postoperative period in both cardiothoracic and noncardiothoracic settings. [4] [5] [6] [7] [8] [9] [10] In fact, it has been shown that the association between perioperative AF and long-term risk of stroke is stronger for noncardiac than for cardiac surgical procedures. 4 The literature on the effects of postoperative AF in the realm of vascular surgery is sparse. The purpose of this study was to measure the incidence rates and effects of transient postoperative AF (TPAF) after open revascularization of the abdominal aorta and its branch vessels (AAB) for occlusive lesions on length of stay (LOS), readmission, and short-and long-term mortality rates. An additional goal was to develop a clinically applicable predictive model to identify patients at risk of TPAF. (HCUP SID) . 11 The HCUP SID was developed through sponsorship by the Agency for Healthcare Research and Quality to inform healthrelated decisions. 12 It includes all patient discharge records, regardless of payer, for the states that participate in the project. Data include >100 clinical and nonclinical variables and are deidentified and protected. 12, 13 Each individual within each SID is assigned a unique linkage variable, enabling longitudinal assessment of inpatients. In addition, the HCUP SID includes present-onadmission indicators, allowing differentiation between pre-existing and new-onset conditions during an inpatient hospitalization. The study was determined to be exempt from Institutional Review Board approval on the basis of the use of publically available, deidentified patient data. It is neither necessary nor possible to obtain informed consent from patients, given the nature of the administrative database.
METHODS
Patient inclusion. All patients $18 years with occlusive disease of the AAB who underwent open revascularization between the years 2007 and 2010 were identified using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure codes. The first intervention was considered for patients who had multiple admissions in which they had revascularization procedures done. Inpatient stays from 2006 (to include at least 1 year of preoperative hospitalizations) combined with any diagnosis designated "present on admission" were used to identify preoperative medical comorbidities and any diagnosis of AF within 1 year preceding the procedure. In addition, inpatient encounters from 2011 were evaluated to identify postoperative admissions and mortality among patients who underwent surgery in 2010 to guarantee a minimum 1-year follow-up. Table I lists the specific ICD-9-CM diagnosis and procedure codes used to identify the study population.
Significant differences exist between aortoiliac occlusive disease and abdominal aortic aneurysm (AAA) with respect to the risk factors (ie, incidence rate of diabetes mellitus and coronary artery disease) and intraoperative variables, such as blood loss and requirement for blood product transfusion. Furthermore, a study on the effects of TPAF on AAA has recently been reported. 9 Thus, patients with a diagnosis of abdominal aortic dissection or aneurysm of the aorta or its branches were excluded to include only patients with occlusive disease as an indication for surgery. Also excluded were those with a pre-existing diagnosis of AF to ensure that all cases were new onset. Finally, to limit procedures to the abdomen, patients who underwent peripheral artery revascularization were also excluded. Fig 1  presents the study design.
Patient characteristics. Patient outcomes were adjusted by demographic characteristics, which included gender and race (white, African American, Hispanic, other), and socioeconomic factors, such as median annual income by zip code ($0-$38,999; $39,000-$47,999; $48,000-$63,999; $64,000þ) and primary insurance type (Medicare, Medicaid, private, other), based on HCUP SID availability.
Clinical characteristics were also accounted for and included comorbidities assigned on the basis of the Agency for Healthcare Research and Quality comorbidity software. This software uses ICD-9-CM codes and diagnosis-related groups to identify conditions not related to the principal diagnosis and to group them into usable categories to describe patients' comorbidity.
14 In addition, the Charlson Comorbidity Index (CCI), which measures the risk of mortality secondary to medical comorbidities, was calculated using ICD-9-CM codes. 15 End points. The diagnosis of AF was identified using the ICD-9-CM diagnosis code 427.31.
1 It was then further classified as TPAF or no-TPAF using the same method the authors have used in previous studies. [8] [9] [10] Two criteria were used to identify patients who developed TPAF. First, the patient should not have had a prior known history of AF (no AF in the 1 year before surgery and no AF present on admission). Second, patients should have developed AF and died during the index admission, did not experience any readmission, or did not present with the arrhythmia on subsequent inpatient encounters (therefore, their AF was transient). No-TPAF patients were those who either did not develop postoperative AF or developed persistent postoperative AF. Persistent postoperative AF was defined as AF that was not documented preoperatively and was present on at least one subsequent encounter within 1 year after surgery. Because the persistent AF group was not large enough to be studied as a separate group, it was combined with the no-TPAF group. Furthermore, it was shown in our earlier studies [8] [9] [10] that its outcomes were similar to those of patients who did not develop AF.
The primary end points of this study were (1) LOS; (2) 30-day and 1-year readmission rates from the day of discharge; and (3) inpatient, 30-day, and 1-year mortality from the day of surgery. For the calculation of readmission rates, all-cause readmission was considered. The overall risk of readmission was assessed because it has been shown that AF can be associated with a broad spectrum of complications.
Statistical analysis. Baseline patient characteristics and the development of TPAF were compared using t-tests for continuous variables and c 2 tests for categorical variables. Time-to-event analysis measuring patient death and first readmission were conducted using the KaplanMeier failure and survival functions.
Unadjusted models were initially built to assess the crude association between TPAF and the three outcomes of interest. Multivariable linear and logistic regression models were fit to estimate the impact of TPAF on LOS and readmission rates. To establish the effect of our treatment (TPAF), first, backwards stepwise regressions were conducted to identify which demographic (age, gender, race, insurance), medical comorbidities (CCI, deficiency anemia, blood loss anemia, obesity, diabetes mellitus, hypertension, congestive heart failure, chronic renal failure, chronic lung disease, coagulation disorders, electrolyte disorders, valvular disease, history of myocardial infarction, smoking history), and surgical factors (number of procedures performed simultaneously) were most associated with each end point. Next, the association between factors found to be significant (P < .05) and TPAF was analyzed, and their influence on the development of TPAF and outcomes was controlled for on a final multivariable regression model. In this way, the effect of our treatment (TPAF) on each outcome was isolated from confounders. Finally, Cox proportional hazards models were constructed to study the association between TPAF and mortality while controlling for patient demographic characteristics, comorbid conditions, and the surgical factors listed before. Statistical analyses were conducted using Stata version 13 (StataCorp LP, College Station, Tex) and RStudio (R x64 3.2.1). All significance tests were two sided, with a P value of .05 considered statistically significant.
Predictive modeling. A predictive model was built to identify predictors of TPAF among patient characteristics using backwards stepwise regression. Demographics, surgical characteristics, and comorbidities were included, and those most associated with the development of TPAF were selected by the model. Training of the model was performed on the California subpopulation (n ¼ 2427). The selected significance level for removal from the model was .05. External validation of the model was done on patient encounters from the state of Florida (n ¼ 2035), identified with the same inclusion and exclusion criteria.
RESULTS
Baseline characteristics. A total of 4462 patients were identified who underwent open revascularization of AAB for occlusive disease in the states of Florida and California between January 2007 and December 2010. None of these patients had a documented prior diagnosis of AF. A majority had undergone aortoiliac/femoral bypass (3253/4462 [72.9%]), followed by endarterectomy of the aorta and other abdominal vessels in 1514 (33.9%) and other bypasses of branch vessels in 288 (6.5%). A concomitant femoral, popliteal, tibial, or peroneal endarterectomy was performed in 1480 (33.2%) patients. The majority of the patients (57.6%) had only one of the studied procedures done during their initial admission, whereas 42.4% underwent two or more procedures simultaneously.
The mean age of the study population was 63.8 6 11.1 years, and 46.3% were female. Most patients were white (80.4%) and covered by either Medicare (52.6%) or private insurance (32.0%). The average CCI was 1.4 6 1.4, and the most frequently comorbid conditions were smoking history (73.0%), hypertension (72.3%), chronic lung disease (38.4%), and fluid and electrolyte disorders (24.9%). Table II summarizes baseline characteristics.
End points. New-onset TPAF was diagnosed in 109 patients and new-onset persistent AF developed in 80 additional patients, resulting in a postoperative AF incidence rate of 4.2%. The incidence of TPAF among our population was 2.4% (109/4462 patients). Patients who developed TPAF were older (71.3 6 9.5 vs 63.6 6 11.0 years; P < .001), were more likely to be covered by Medicare (75.2% vs 52.1%), and had a higher burden of comorbidities (2.2 vs 1.4 mean CCI) than those who did not. Patients with TPAF were also more likely to undergo concomitant procedures and to suffer from anemia, fluid Congestive heart failure 80 (1. and electrolyte disorders, and chronic kidney disease (P < .001; Table III) . Bivariate analysis as well as adjusted analysis showed that TPAF was associated with significantly increased LOS, mortality, and readmission rates. The mean LOS increased from 8.6 to 18.7 days in TPAF patients (P < .001). After adjustment, patients who developed TPAF were found to have an 8.0-day longer LOS (P < .001). Inpatient mortality in the TPAF group was significantly higher (17.4% vs 3.8%; P < .001). Likewise, 1-year mortality was 21.7% higher in patients with TPAF (6.7% vs 28.4% cumulative incidence; P < .001). Adjusted odds of inpatient and 1-year mortality in patients with TPAF were 1.08 (P ¼ .007) and 1.14 (P < .001) compared with those without. Finally, whereas 70.6% of the patients who developed TPAF had been readmitted at least once within 1 year of discharge, the corresponding figure was only 39.3% in the no-TPAF group. Cox proportional hazards models revealed a more than twofold increase in mortality rates at 1 month and 1 year (hazard ratio, 2.01 [P ¼ .005] and 2.32 [P < .001], respectively) in the TPAF group compared with the no-TPAF group. Results of multivariable analysis are presented in Table IV . Failure and survival analyses of 1-year readmission and mortality outcomes are presented in Figs 2  and 3 , respectively. 
DISCUSSION
This study demonstrates that TPAF is associated with increased LOS as well as with higher short-term and 1-year readmission and mortality rates in patients undergoing open revascularization of AAB. It also shows that fluid and electrolyte derangements, higher CCI, and increasing age are predictive of TPAF.
The pathogenesis of postoperative AF is multifactorial. It occurs more commonly after cardiothoracic than after noncardiothoracic procedures because violation of the thoracic cavity, direct cardiac manipulation, and disturbance of the electrical conduction system, which is intrinsic to cardiothoracic surgery, portend its development. In noncardiothoracic surgery, postoperative myocardial ischemia, electrolyte imbalance, and physiologic insults from fluid shifts and other perioperative stresses may destabilize the underlying cardiac disease and contribute to its development. Perioperative use of catecholamines, beta-blocker withdrawal, and inadequate pain management have also been implicated. [17] [18] [19] The type of procedure also affects the incidence of postoperative AF as well. Higher incidence rates of new-onset AF have been reported with open repair compared with endovascular repair of AAA. 9, 20 Adverse effects of new-onset postoperative AF after noncardiac surgery have been increasingly recognized. Bhave et al found a 3.0% incidence of AF after major noncardiac surgery at 375 U.S. hospitals and that it was associated with higher mortality and cost and longer hospital stay. 21 In another comprehensive review of all surgical patients between 2007 and 2010 using the HCUP database from California, Gialdini et al observed not only an association between perioperative AF and long-term risk of stroke but also a stronger association for noncardiac than for cardiac surgical procedures. 4 More recently, Blackwell et al reported a 5.3% rate of new-onset TPAF and a higher incidence of cardiovascular events in patients with the arrhythmia at 1 year after radical cystectomy (24.8% vs 10.9%). 8 Nassoiy et al found an 8.1% incidence rate of AF that was also associated with a significantly higher incidence of cardiovascular complications in gastrectomy patients (16.7% vs 4.5%).
10 Surprisingly, the effects of new-onset AF after vascular surgery, in which the prevalence of coronary atherosclerotic disease is higher than in other noncardiac surgery, remain poorly defined. 22 Valentine et al reported a 10%
incidence of new-onset AF in a survey of 211 thoracic and abdominal aortic repairs under continuous postoperative electrocardiographic surveillance; no association between new-onset AF and outcomes of aortic surgery was noted. 23 Noorani et al also observed a 10% incidence of AF in a review of 200 elective open AAA repairs. 24 In that series, a longer LOS and a higher risk of cardiac failure were observed in patients with new-onset AF compared with those without; however, no survival difference was noted. Winkel et al found a 4.7% incidence rate of new-onset AF after 317 major vascular surgical procedures and that the arrhythmia was associated with a fivefold increased risk for postoperative cardiovascular complications, an effect that persisted at 1 postoperative year. 19 In an earlier study, the authors reported a 5.5-fold increase in postoperative acute myocardial infarction rates, increased 1-year postoperative mortality, and postdischarge mortality in patients who developed TPAF after both open and endovascular repair of AAA. 9 The present study reconfirms the association of TPAF and adverse outcomes after vascular surgery that extends beyond the postoperative period. The incidence of TPAF in the current study is relatively lower at 2.4% compared with 9.3% after open repair of AAA that was reported by the authors' earlier study and 10% reported by the aforementioned other studies. 9, 23, 24 This difference may be related to the higher incidence of angiographically proven severe coronary artery disease in patients with AAA compared with those with aortoiliac and lower extremity occlusive diseases as reported by Hertzer et al. 22, 25 It may also be related to decreased blood loss and transfusion requirement, which may result in less fluid shift after aortic reconstruction for occlusive disease compared with aneurysmal disease. A higher incidence of postoperative organ dysfunction, increased LOS, and higher late mortality have been shown after aortic reconstruction for aneurysm repair vs occlusive disease. 26, 27 Finally, the true incidence of newonset AF may be under-reported because not all patients are routinely observed by continuous postoperative electrocardiographic monitoring. Nonetheless, the findings in the current study further reinforce the association of TPAF with unfavorable surgical outcomes, not only in the perioperative period but also affecting readmission rates up to 1 year. This adverse association between TPAF and outcomes also results in higher cost of care. Bhave et al 21 estimated
an adjusted mean increase of $5914 in costs when TPAF developed, whereas Vaporciyan et al 18 noted a twofold increase in costs, which represented an extra $28,100. Although cost analysis was not conducted in the present study, the increased LOS and readmission rates in patients with TPAF indicate increased cost of care in this group of patients. Together, the results of the current study add to a growing body of literature emphasizing the need for improved perioperative care of TPAF. The authors have employed a strategy to identify patients who are at highest risk for development of TPAF using predictive analytic techniques leveraging readily available clinical data. 9 For patients requiring operative repair of AAA, we have developed a web-based, predictive tool that can be used at the point of care to successfully determine the probability that a patient will develop TPAF. In the current study, fluid and electrolyte disorders, increasing age, and higher CCI were the strongest factors associated with TPAF and are being integrated into our existing predictive tool to guide the management of this specific surgical population. Systematic perioperative risk assessment to identify at-risk patients for TPAF could lead to the implementation of measures to prevent the development of TPAF and consequent adverse outcomes and reduce costs. Several perioperative prophylactic measures have been proposed to lower the incidence of postoperative AF. Beta-blockade is one of the most accepted and effective ones and can help compensate for the increased perioperative sympathetic outflow, and beta blockers are usually preferred to amiodarone or sotalol, if no contraindications are present. 17, 28 Tight patient monitoring in the postoperative period could help correct predisposing factors and treat AF early in cases in which it was not preventable. Adequate postoperative pain relief, optimization of oxygenation, and maintenance of a state of euvolemia are some of the interventions that could benefit patients even beyond preventing TPAF. Thoracic epidural anesthesia has been postulated as a protective intervention because of its direct negative chronotropic effect on the heart and a reduction of the sympathetic outflow elicited by pain. 17 Less used strategies include the administration of antioxidants such as statins, N-acetylcysteine, and vitamin C. 17 In addition, decreased mortality and readmissions could be achieved by ensuring close follow-up after discharge in these at-risk patients. Antiplatelet agents could also play a role in the prevention of cardiovascular events in patients who develop postoperative AF. The analysis uses the ROC curve, which illustrates the model's performance as its discrimination threshold is varied, by plotting sensitivity vs 1 À specificity. The sensitivity is the fraction of positive cases that are correctly classified by the model, whereas the specificity is the fraction of negative cases that are correctly classified. Thus the sensitivity is the truepositive rate, and the specificity is the true-negative rate.
This study suffers from the usual limitations of an administrative database that have been reported. 30, 31 Specifically, relevant clinical details, such as use of perioperative beta blockers, fluid shifts, treatment interventions, and duration of TPAF, cannot be ascertained. A more detailed database, possibly institutional data, would be a good next step to further study this issue in more detail after defining its relevance with an administrative database. In addition, nonbillable or low-revenue diagnoses such as AF may be under-reported, leading to an underestimation of its incidence. Administrative databases may also contain inaccuracies due to reporting or coding errors, and the HCUP SID in particular does not include outpatient encounters or mortality data. 32, 33 Furthermore, only two states were included in the analysis, and for this reason, caution is needed in extrapolating these data to the whole population. Finally, causal relationships cannot be established because of the study's retrospective nature.
CONCLUSIONS
TPAF after revascularization of AAB is associated with increased LOS as well as with short-and long-term mortality and hospital readmission rates. Close follow-up of these at-risk patients is recommended up to at least 1 year after discharge. Furthermore, strategies to identify patients vulnerable to the development of TPAF could lead to the implementation of focused and appropriate prophylactic measures that may improve surgical outcomes and reduce cost of care. 
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